Drug-induced cardiac mitochondrial toxicity and protection: from doxorubicin to carvedilol.
about
Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative StressMitochondrionopathy phenotype in doxorubicin-treated Wistar rats depends on treatment protocol and is cardiac-specificSulforaphane protects the heart from doxorubicin-induced toxicityArsenic trioxide and resveratrol show synergistic anti-leukemia activity and neutralized cardiotoxicityExercise and Doxorubicin Treatment Modulate Cardiac Mitochondrial Quality Control Signaling.Synergistic inhibition of leukemia WEHI-3 cell growth by arsenic trioxide and Hedyotis diffusa Willd extract in vitro and in vivo.Quercetin attenuates doxorubicin cardiotoxicity by modulating Bmi-1 expression.Mitochondrial pharmacology: electron transport chain bypass as strategies to treat mitochondrial dysfunction.Analysis of mtDNA, miR-155 and BACH1 expression in hearts from donors with and without Down syndrome.Sirtuin-3 (SIRT3) Protein Attenuates Doxorubicin-induced Oxidative Stress and Improves Mitochondrial Respiration in H9c2 Cardiomyocytes.Scaffold Free Bio-orthogonal Assembly of 3-Dimensional Cardiac Tissue via Cell Surface Engineering.Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.Current status of drug screening and disease modelling in human pluripotent stem cells.Drug-induced oxidative stress and toxicity.p66Shc signaling is involved in stress responses elicited by anthracycline treatment of rat cardiomyoblasts.Current views on anthracycline cardiotoxicity.Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine.The Protective Role of Phenolic Compounds Against Doxorubicin-induced Cardiotoxicity: A Comprehensive Review.Carvedilol and antioxidant proteins in a type I diabetes animal model.Differentiation-dependent doxorubicin toxicity on H9c2 cardiomyoblasts.Low-dose carvedilol protects against acute septic renal injury in rats during the early and late phases.Triphenyl Phosphine-Functionalized Chitosan Nanoparticles Enhanced Antitumor Efficiency Through Targeted Delivery of Doxorubicin to Mitochondria.MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2.Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells.Protective effect of paracetamol in doxorubicin-induced cardiotoxicity in ischemia/reperfused isolated rat heart.Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model.The Cardiotoxic Mechanism of Doxorubicin (DOX) and Pegylated Liposomal DOX in Mice Bearing C-26 Colon Carcinoma: a Study Focused on microRNA Role for Toxicity Assessment of New Formulations.A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth
P2860
Q26780547-6C41AA6D-16AF-4F90-9141-CDDE40351391Q27301261-D31F2D89-7409-47B5-AFB7-B37E2B572E2BQ28387218-90710CCA-3185-4C9E-84DC-A9BF2B503C0AQ28542497-9FB175B8-B153-4C11-9674-85D60BAFBE63Q32872193-4E908EB5-7974-48CF-96D5-FB0AA53E83D4Q33744923-D43CFD2F-BFEB-492F-8ECB-E3851996CC39Q34402813-3C58A3BD-7EF4-4332-AE2F-9333135125BBQ34988040-4374FFE9-8C94-4355-AE37-81BDF012986BQ35044480-C916EF8F-B77D-48CB-A2FF-44BFD127D71FQ35536301-36F29D3B-673E-44B2-9985-19DF68F1833DQ37529345-BD7C1905-C8AA-4F4D-9D35-3226F4B489D5Q37573646-2752AD35-5195-47FB-B303-6824CD43F2DDQ38034129-71ECF93C-0C5E-4FA4-962D-E533EE009E0DQ38037517-302C3C65-D0A2-4602-BCD4-0E4BA84C1853Q38839763-C7FA86AE-FCC9-4B80-B11A-B29AB78E258BQ38845535-B7BCB9A0-EA92-4025-8E96-60FF08B4C7C5Q38874111-BCFDC41F-E66C-42DD-B065-A1EFA65B40CDQ38875916-F75C920B-85A8-4790-92C1-A62B2A19E854Q39224330-9D0F9652-0613-4CD7-A689-C68A48981CB6Q39323215-D47BA909-18BF-4783-8C7D-FC4B07699102Q41269792-87570F70-7827-4AB4-BE21-4AA6D48C608DQ42255827-D47EEA08-0754-470D-AA90-766D89787121Q47204916-42CDCFF5-7434-4CC8-9E07-9AA44C895163Q47611653-4CFE98F0-A37C-4F40-9F51-4BF97E595AB2Q49925425-61EF5E69-9989-4445-B457-C3D9DE8BA81CQ50420344-4D7B8A54-4F7B-4150-8944-B97A504709A8Q50611647-32A5837C-B1D5-499B-839D-43E3E3703892Q58790268-540EDCA3-BB8D-48B7-A0C4-3CC997663552
P2860
Drug-induced cardiac mitochondrial toxicity and protection: from doxorubicin to carvedilol.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drug-induced cardiac mitochond ...... rom doxorubicin to carvedilol.
@en
Drug-induced cardiac mitochond ...... rom doxorubicin to carvedilol.
@nl
type
label
Drug-induced cardiac mitochond ...... rom doxorubicin to carvedilol.
@en
Drug-induced cardiac mitochond ...... rom doxorubicin to carvedilol.
@nl
prefLabel
Drug-induced cardiac mitochond ...... rom doxorubicin to carvedilol.
@en
Drug-induced cardiac mitochond ...... rom doxorubicin to carvedilol.
@nl
P2093
P50
P1476
Drug-induced cardiac mitochond ...... from doxorubicin to carvedilol
@en
P2093
Ana M Silva
Cátia V Diogo
Filipa S Carvalho
P304
P356
10.2174/138161211796904812
P577
2011-01-01T00:00:00Z